Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IC43 in Intensive Care Patients
NCT00876252Phase 2Completed
- Sponsor
- Valneva
- Start
- Dec 2008
- Primary completion
- Feb 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of IC43 in ventilator-associated pneumonia (VAP), Pseudomonas aeruginosa infection, sponsored by Valneva. Started Dec 2008; status: completed.
02
Drugs
IC43
03
Conditions
ventilator-associated pneumonia (VAP)Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT00876252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00876252.